Discover investment opportunities in Top 10 Stocks Under $11 using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Top 10 Stocks Under $11 using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Top 10 Stocks Under $11 using our Smart AI Filter.
8 stocks found for "Top 10 Stocks Under $11"
Security name | Expected returns | Sharpe Ratio | Beta | Volatility | P/E Ratio | Dividend Yield |
|---|---|---|---|---|---|---|
1.75 | ±61.5% | 12.2 | 0.71% | |||
0.91 | ±100.0% | -0.5 | 0.00% | |||
0.76 | ±84.3% | -3.2 | 0.00% | |||
1.25 | ±77.5% | -41.9 | 0.00% | |||
0.97 | ±100.0% | -55.4 | 0.00% | |||
0.47 | ±100.0% | -0.2 | 0.00% | |||
0.80 | ±100.0% | -0.1 | 0.00% | |||
1.28 | ±77.0% | -14.1 | 0.00% |
This search uses our Smart AI Filter to identify stocks matching your criteria. Results are ranked by relevance and include key financial metrics to help you make informed investment decisions.
Get personalized stock recommendations, save custom screens, and access premium filters. All our screening tools are free—signing up gives you more personalized results and the ability to save your research.
Compliance disclosure:
The securities listed on this website have not paid to be included in the results. The inclusion of any securities in the results shown does not imply any relationship with PortfolioPilot. The order of the results is ranked based on the Sharpe Ratio, which is a measure of risk-adjusted return. Please note that these listings are not recommendations or financial advice. Past performance is not indicative of future results.
Q: Why might investors be interested in ALTM for growth potential?
A: ALTM, as an infrastructure company, plays a significant role in the energy sector. Its growth potential is linked to fossil fuel demand and infrastructure expansion in North America. Historical performance suggests it benefits during periods of increased energy infrastructure investment.
Q: How does ARQT's market presence potentially impact its stock appeal?
A: ARQT, a biotech firm, focuses on unique dermatological therapies, making its innovations critical for niche markets. Its stock appeal may rise with successful product development and favorable FDA reviews, though it carries inherent sector volatility.
Q: What factors contribute to XPEV's attractiveness in the EV market?
A: XPEV is in the burgeoning electric vehicle sector, gaining appeal due to China's large consumer base and supportive EV policies. Investors are interested in its innovation, comparative production costs, and growth in the global EV market.
Q: Does SOUN have the potential to drive income through its business model?
A: SOUN, focusing on AI-driven services, may not offer immediate income potential through dividends. Investors may view its growth in AI applications and licensing revenue as long-term income sources, barring current financial constraints.
Q: What are the risks of investing in FFIE given its market position?
A: FFIE, active in the electric vehicle industry, faces risks like high competition, regulatory obstacles, and capital expenditure demands. Its competitiveness depends on brand recognition, technological advances, and production capabilities.
Q: Can KZIA offer stability to a portfolio during economic volatility?
A: KZIA, specializing in biotech pharmaceuticals, may not provide stability but offers diversification benefits. Biotech stocks typically weather economic downturns differently due to ongoing demand for healthcare solutions, albeit with higher risk.
Nio, Leapmotor, and Xpeng broke their delivery records on new, affordably-priced models. However, Li Auto sales saw its third month of decline in August despite launching a model with competitive pricing, following a controversial test video.
Read moreFrom a humble start at $2 in early 2024, SoundHound AI (NASDAQ: SOUN), a voice AI platform enabling businesses to deliver conversational AI experiences, has seen its stock skyrocket by an astonishing 500% to its current price of around $13. This explosive ascent isn't just luck; it's a direct result of the company's compelling AI growth story, which has seen its technology become a staple in the automotive industry and expand into new frontiers.
Read moreKazia Therapeutics Limited KZIA stock is trading lower on Tuesday after the company provided a regulatory update on paxalisib for glioblastoma (GBM) following its Type C clinical meeting with the FDA.
Read more